Question 1

What is Ivan Salladay-Perez?

Accepted Answer

Ivan Salladay-Perez is a Person.

Question 2

How often does Ivan Salladay-Perez appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Ivan Salladay-Perez first tracked by Ergen?

Accepted Answer

First tracked on Apr 16, 2026.

Question 4

When was Ivan Salladay-Perez last mentioned in news?

Accepted Answer

Last active on Apr 20, 2026.

Question 5

What is Ivan Salladay-Perez's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Ivan Salladay-Perez in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Ivan Salladay-Perez?

Accepted Answer

UCLA identifies 'zombie cells' reversing liver damage (Apr 16, 2026, 6 articles).

Question 8

How did the "UCLA identifies 'zombie cells' reversing liver damage" event impact Ivan Salladay-Perez?

Accepted Answer

Ivan Salladay-Perez is the first author of the study, contributing significantly to the research on senescent macrophages and their role in liver disease.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.